University of Queensland scientists have developed a world-first method for producing adult stem cells that will substantially impact patients who have a range of serious diseases.
The research is a collaborative effort involving UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) and is led by UQ Clinical Research Centre’s (UQCCR) Professor Nicholas Fisk.
It revealed a new method to create mesenchymal stem cells (MSCs), which can be used to repair bone and potentially other organs.
“We used a small molecule to induce embryonic stem cells over a 10 day period, which is much faster than other studies reported in the literature,” Professor
A new biomaterial that enhances the ability of stem cells to regenerate into nerves and body parts has been developed by Australian and British scientists.
The work was a result of a joint study undertaken by the researchers at the Melbourne-based Monash University and UK-based University of Warwick.
Other biomedical “scaffold” materials, which act as templates for tissue regeneration, already exist but they cannot communicate effectively with the cells they are trying to influence.
The researchers have created a more advanced material that targets specific cells and provides clear signals to these cells to enhance regeneration.
Unlocking knowledge about how organisms develop and repair, stem cell research holds great promise for future therapies for injuries and conditions, from infertility and Alzheimer’s to heart failure and cancer. As part of its mission to promote cross-campus interactions and enhance training in stem cell biology at Cornell, the Cornell Stem Cell Program (CSCP) held its second Stem Cell Retreat May 17 on campus.
About 85 members of the Cornell stem cell research community attended the event, which featured keynote speaker Dr. Lawrence Goldstein, director of the Stem Cell Program at University of California, San Diego, and the Howard Hughes
University of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. Their success brings stem cell therapies another step closer.
To prove the cells’ regenerative powers, bone cells grown on this surface were then transplanted into holes in the skulls of mice, producing four times as much new bone growth as in the mice without the extra bone cells.
An embryo’s cells really can be anything they want to be when they grow up: organs, nerves, skin, bone, any type of human cell. Adult-derived “induced” stem
A team led by Peter Schultz, Scripps Family Chair Professor and member of the Skaggs Institute for Chemical Biology at The Scripps Research Institute, has been awarded a $4.3 million grant from the California Institute for Regenerative Medicine (CIRM) to research stem-cell-based therapies to treat multiple sclerosis.
Because stem cells can change or differentiate into many different cell types (such as nerve cells, muscle cells, and skin cells), they hold the life-changing medical potential to provide a source of cells to replace those permanently lost by a patient.
The Scripps Research project focuses on restoring the myelin sheath—a protective covering that